99mTc-Hydrazinonicotinic acid-cyclo[γ- d -Glu-Ala-Tyr- d -Lys]-Trp-Met-Phe-NH2
- PMID: 20641978
- Bookshelf ID: NBK26805
99mTc-Hydrazinonicotinic acid-cyclo[γ- d -Glu-Ala-Tyr- d -Lys]-Trp-Met-Phe-NH2
Excerpt
The gastrointestinal peptides gastrin and cholecystokinin-2 (CCK2) have various regulatory functions in the brain and gastrointestinal tract (1). Both peptides have the same COOH-terminal pentapeptide amide sequence, GWMDF-NH2, which is the biologically active site (2). Human gastrin is a peptide composed of 33 amino acids and also exists in several C-terminal–truncated forms (3). These truncated forms include minigastrin (MG0), which is a 13-residue peptide with the sequence of
A cyclized minigastrin analog, cyclo[γ-
Sections
References
-
- Reubi J.C., Schaer J.C., Waser B. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. . Cancer Res. 1997;57(7):1377–86. - PubMed
-
- Aly A., Shulkes A., Baldwin G.S. Gastrins, cholecystokinins and gastrointestinal cancer. . Biochim Biophys Acta. 2004;1704(1):1–10. - PubMed
-
- Wang H., Wong P.T., Spiess J., Zhu Y.Z. Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats. . Neurosci Biobehav Rev. 2005;29(8):1361–73. - PubMed
-
- Behr T.M., Behe M.P. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. . Semin Nucl Med. 2002;32(2):97–109. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous